MYCN and neuroblastoma: We selected 15 neuroblastoma cell lines previously reported to harbor MYCN and/or ALK amplifications, gains or the normal diploid chromosomal complements in the regions of MYCN and ALK as a panel in which to validate detection of gene amplification or gain by ddPCR.